First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors
NCT01469052
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
AG-013736
DRUG:
AG-013736
DRUG:
AG-013736
DRUG:
AG-013736
DRUG:
AG-013736
DRUG:
AG-013736
Sponsor
Pfizer